Analyst Ratings For Darling Ingredients
Within the last quarter, Darling Ingredients (NYSE:DAR) has observed the following analyst ratings:
Last 30 Days
1 Month Ago
2 Months Ago
Raymond James Maintains Strong Buy on Darling Ingredients, Raises Price Target to $105
Raymond James analyst Justin Jenkins maintains Darling Ingredients (NYSE:DAR) with a Strong Buy and raises the price target from $95 to $105.
What 10 Analyst Ratings Have To Say About Darling Ingredients
Darling Ingredients (NYSE:DAR) has observed the following analyst ratings within the last quarter:
Last 30 Days
1 Month Ago
2 Months Ago
Baird Maintains Outperform on Darling Ingredients, Raises Price Target to $109
Baird analyst Ben Kallo maintains Darling Ingredients (NYSE:DAR) with a Outperform and raises the price target from $89 to $109.
Stephens & Co. Maintains Overweight on Darling Ingredients, Raises Price Target to $89
Stephens & Co. analyst Ben Bienvenu maintains Darling Ingredients (NYSE:DAR) with a Overweight and raises the price target from $86 to $89.
Credit Suisse Maintains Outperform on Darling Ingredients, Raises Price Target to $100
Credit Suisse analyst Manav Gupta maintains Darling Ingredients (NYSE:DAR) with a Outperform and raises the price target from $95 to $100.
Unusual Options Activity Insight: Darling Ingredients
Darling Ingredients (NYSE:DAR) shares experienced unusual options activity on Wednesday. The stock price moved down to $73.05 following the option alert.
Darling Ingredients: Q2 Earnings Insights
Shares of Darling Ingredients (NYSE:DAR) rose in after-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share were up 200.00% year over year to $1.17, which beat the estimate of $0.82.
Darling Ingredients Q2 GAAP EPS $1.17 May Not Compare To $0.82 Estimate, Sales $1.20B Beat $1.13B Estimate
Darling Ingredients (NYSE:DAR) reported quarterly earnings of $1.17 per share which beat the analyst consensus estimate of $0.82 by 42.68 percent. This is a 200 percent increase over earnings of $0.39 per share from the
Earnings Scheduled For August 10, 2021
Companies Reporting Before The Bell
• Nautilus Biotechnology (NASDAQ:NAUT) is expected to report earnings for its second quarter.